ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.505,70
0,47%
S&P 500
6.034,14
0,66%
Dow Jones
44.539,77
0,27%
Euro vs US Dollar
1,03845
0,55%
Bitcoin
99.691,03
-1,71%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. TSXV

  6. Theralase Technologies Inc (TLT) Börsenkurse

Theralase Technologies Inc

Theralase Technologies Inc (TLT)

Tilt Renewables Limited
The London Tunnels PLC
iShares 20+ Year Treasury Bond ETF
iShares 20 plus Year Treasury Bond
0,255
-0,015
( -5,56% )
Aktualisiert: 19:28:09
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
0,255
Gebot
0,25
Fragen
0,26
Volumen
113.942
0,255 Tagesbereich 0,27
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
58,257M
Handelsende
0,27
Handelsbeginn
0,27
Letzte Trade
5000
@
0.255
Letzter Handelszeitpunkt
19:28:09
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
228.460.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-12,50
Gewinn pro Aktie (EPS)
-0,02
Erlöse
1,07M
Nettogewinn
-4,57M

Über Theralase Technologies Inc

Sektor
Electromedical Apparatus
Branche
Electromedical Apparatus
Website
www.theralase.com
Hauptsitz
Toronto, Ontario, Can
Gegründet
-
Theralase Technologies Inc is listed in the Electromedical Apparatus sector of the TSX Venture Börse with ticker TLT. The last closing price for Theralase Technologies was $0,27. Over the last year, Theralase Technologies shares have traded in a share price range of $ 0,00 to $ 0,00.

Theralase Technologies currently has 228.460.000 shares in issue. The market capitalisation of Theralase Technologies is $61,68 million. Theralase Technologies has a price to earnings ratio (PE ratio) of -12.50.

TLT Neueste Nachrichten

Weitere Nachrichten

Theralase® Releases FY2022 Audited Financial Statements

TORONTO, April 26, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the...

27 April 2023
GlobeNewswire Inc.

Theralase® Phase II NMIBC Clinical Study (Interim) Data Presented at the ASCO GU Cancer Symposium

TORONTO, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the...

23 Februar 2023
GlobeNewswire Inc.

Theralase® Awarded TSX Venture 50™ Recognition as a Top Performing Company

TORONTO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the...

21 Februar 2023
GlobeNewswire Inc.

Theralase® Phase II NMIBC Clinical Study (Interim) Data to be Presented at the AUA Annual Meeting

TORONTO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the...

02 Februar 2023
GlobeNewswire Inc.

Theralase® Phase II NMIBC Clinical Study (Interim) Data to be Presented at the ASCO GU Cancer Symposium

TORONTO, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the...

25 Januar 2023
GlobeNewswire Inc.

Theralase ® Announces Warrant Extension

TORONTO, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or “Company”) (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and...

06 Januar 2023
GlobeNewswire Inc.

Theralase Releases Q322 Interim Financial Statements

TORONTO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the...

30 November 2022
GlobeNewswire Inc.

Theralase® Grants Stock Options

TORONTO, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the...

21 November 2022
GlobeNewswire Inc.

Theralase ® Closes Private Placement Equity Financing

TORONTO, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the...

17 November 2022
GlobeNewswire Inc.

Theralase® Commences $CAN 2.5 M Follow-On Private Placement Equity Financing

Not for distribution to U.S. news wire services or dissemination in the United States. TORONTO, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”...

03 Oktober 2022
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

TLT - Frequently Asked Questions (FAQ)

What is the current Theralase Technologies share price?
The current share price of Theralase Technologies is $ 0,255
How many Theralase Technologies shares are in issue?
Theralase Technologies has 228.460.000 shares in issue
What is the market cap of Theralase Technologies?
The market capitalisation of Theralase Technologies is CAD 61,68M
What is the 1 year trading range for Theralase Technologies share price?
Theralase Technologies has traded in the range of $ 0,00 to $ 0,00 during the past year
What is the PE ratio of Theralase Technologies?
The price to earnings ratio of Theralase Technologies is -12,5
What is the cash to sales ratio of Theralase Technologies?
The cash to sales ratio of Theralase Technologies is 53,19
What is the reporting currency for Theralase Technologies?
Theralase Technologies reports financial results in CAD
What is the latest annual turnover for Theralase Technologies?
The latest annual turnover of Theralase Technologies is CAD 1,07M
What is the latest annual profit for Theralase Technologies?
The latest annual profit of Theralase Technologies is CAD -4,57M
What is the registered address of Theralase Technologies?
The registered address for Theralase Technologies is 41 HOLLINGER ROAD, TORONTO, ONTARIO, M4B 3G4
What is the Theralase Technologies website address?
The website address for Theralase Technologies is www.theralase.com
Which industry sector does Theralase Technologies operate in?
Theralase Technologies operates in the ELECTROMEDICAL APPARATUS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ROCKEros Resources Corp
 0,065
(333,33%)
529k
NICKNickelex Resource Corporation
$ 0,01
(100,00%)
154k
TVITVI Pacific Inc
$ 0,01
(100,00%)
150k
PORPortofino Resources Inc
$ 0,01
(100,00%)
240k
FUNDKatipult Technology Corp
$ 0,01
(100,00%)
20k
GBUGabriel Resources Ltd
$ 0,005
(-50,00%)
104k
DMDataMetrex AI Limited
$ 0,005
(-50,00%)
2,18M
NZPChatham Rock Phosphate Limited
$ 0,055
(-35,29%)
9k
SCLTSearchlight Resources Inc
$ 0,01
(-33,33%)
242k
HBKHighbank Resources Ltd
$ 0,01
(-33,33%)
35k
WGOWhite Gold Corp
$ 0,17
(0,00%)
11,19M
GPUSAlset AI Ventures Inc
$ 0,115
(15,00%)
3,31M
OMIOrosur Mining Inc
$ 0,175
(52,17%)
3,31M
DMDataMetrex AI Limited
$ 0,005
(-50,00%)
2,18M
XBOTRealbotix Corp
$ 0,52
(4,00%)
2M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

TSXV
TLT
Theralase Technologies
BIT
NSCIT0497650
Italy
BIT
CM9
Amundi ETF MSCI World Ex...
BIT
UC20SG
Unicredit Bank
TSX
ISTE
Invesco S&P 500 ESG Tilt...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten